Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
주식 순위 #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
주가
$29.06
마지막 동기화: 2023-02-23
시가총액
$682.73M
변동 (1일)
-0.48%
변동 (1년)
0.00%
국가
US
거래 CinCor Pharma, Inc. (CINC)

카테고리

CinCor Pharma, Inc. (CINC)의 주가 이력
최고 종가: $29.26 (2023-02-01 기준)

최저 종가: $16.50 (2022-01-01 기준)
CinCor Pharma, Inc.의 주가 이력 (2022 ~ 2026)
연간 주가 성과
연도 성과
2023 146.11%
2022 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH